Capital Fund Management S.A. Buys New Stake in Vitamin Shoppe Inc. (VSI)
Capital Fund Management S.A. bought a new position in shares of Vitamin Shoppe Inc. (NYSE:VSI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,100 shares of the company’s stock, valued at approximately $339,000.
A number of other large investors have also bought and sold shares of VSI. Daiwa Securities Group Inc. increased its stake in Vitamin Shoppe by 932.1% in the second quarter. Daiwa Securities Group Inc. now owns 7,400 shares of the company’s stock worth $226,000 after buying an additional 6,683 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in Vitamin Shoppe by 95.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,461 shares of the company’s stock worth $259,000 after buying an additional 4,126 shares in the last quarter. Bank of Montreal Can acquired a new stake in Vitamin Shoppe during the second quarter worth approximately $425,000. Menta Capital LLC increased its stake in Vitamin Shoppe by 102.9% in the first quarter. Menta Capital LLC now owns 14,200 shares of the company’s stock worth $440,000 after buying an additional 7,200 shares in the last quarter. Finally, BlackRock Group LTD increased its stake in Vitamin Shoppe by 7.3% in the first quarter. BlackRock Group LTD now owns 37,164 shares of the company’s stock worth $1,150,000 after buying an additional 2,521 shares in the last quarter.
Vitamin Shoppe Inc. (NYSE:VSI) traded up 0.81% on Friday, hitting $27.47. The stock had a trading volume of 225,844 shares. The company’s 50-day moving average is $27.16 and its 200-day moving average is $28.94. Vitamin Shoppe Inc. has a one year low of $26.02 and a one year high of $34.41. The stock has a market cap of $647.85 million, a P/E ratio of 16.09 and a beta of 0.55.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by $0.04. Vitamin Shoppe had a return on equity of 11.53% and a net margin of 3.56%. The business had revenue of $332.70 million for the quarter, compared to analyst estimates of $331.58 million. During the same quarter last year, the business earned $0.57 EPS. Vitamin Shoppe’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, analysts anticipate that Vitamin Shoppe Inc. will post $2.18 earnings per share for the current fiscal year.
A number of equities research analysts have commented on the company. Jefferies Group restated a “hold” rating and issued a $28.00 target price on shares of Vitamin Shoppe in a research report on Monday, September 26th. Wedbush reiterated an “outperform” rating and issued a $39.00 price objective on shares of Vitamin Shoppe in a report on Wednesday, August 3rd. Zacks Investment Research upgraded Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Thursday, October 6th. Finally, Barclays PLC initiated coverage on Vitamin Shoppe in a report on Thursday, September 22nd. They issued an “equal weight” rating and a $29.00 price objective on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $32.27.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc. (NYSE:VSI).
Receive News & Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related companies with MarketBeat.com's FREE daily email newsletter.